O
NXTM

OppenheimerFunds’s NxStage Medical Inc. NXTM Stock Holding History

OppenheimerFunds’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-397,867
Closed -$11.1M – 1847
2018
Q2 		$11.1M Buy
397,867
+10,265
+3% +$275K 0.01% 702
2018
Q1 		$9.64M Sell
387,602
-38,282
-9% -$931K 0.01% 699
2017
Q4 		$10.3M Sell
425,884
-451,805
-51% -$11.9M 0.01% 728
2017
Q3 		$24.2M Sell
877,689
-1,637
-0.2% -$43.7K 0.03% 499
2017
Q2 		$22M Sell
879,326
-405,428
-32% -$10M 0.03% 534
2017
Q1 		$34.5M Buy
1,284,754
+454,147
+55% +$12.5M 0.04% 407
2016
Q4 		$21.8M Buy
830,607
+35,386
+4% +$875K 0.03% 552
2016
Q3 		$19.9M Buy
795,221
+24,272
+3% +$566K 0.02% 569
2016
Q2 		$16.7M Buy
770,949
+10,805
+1% +$193K 0.02% 605
2016
Q1 		$11.4M Buy
760,144
+31,991
+4% +$536K 0.02% 698
2015
Q4 		$16M Buy
728,153
+14,578
+2% +$272K 0.02% 633
2015
Q3 		$11.3M Buy
713,575
+27,423
+4% +$440K 0.02% 693
2015
Q2 		$9.8M Sell
686,152
-831,863
-55% -$14.1M 0.01% 757
2015
Q1 		$26.3M Buy
1,518,015
+849,999
+127% +$15M 0.03% 521
2014
Q4 		$12M Buy
+668,016
New +$10.8M 0.01% 721

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

OppenheimerFunds's NXTM Position: Q3 2018 in Review

OppenheimerFunds sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 397,867 shares — an estimated $11.1M sold.

OppenheimerFunds first reported a position in NXTM in Q4 2014 and held it in 15 quarters. The position peaked at $34.5M in Q1 2017. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • OppenheimerFunds reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • OppenheimerFunds sold 397,867 NxStage Medical Inc. shares in Q3 2018, an estimated $11.1M.
  • OppenheimerFunds first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 15 quarters.
  • OppenheimerFunds's NxStage Medical Inc. position peaked at $34.5M in Q1 2017.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on OppenheimerFunds's 13F filing for Q3 2018, filed 13 Nov 2018.